We are seeking exceptional talent for dynamic positions in numerous areas of our Company. Imaging Endpoints is a team of diverse and driven professionals with a goal to change the world by Connecting Imaging to the Cure. Learn more about… Read More
Imaging Endpoints announced today that it has supported another U.S. Food and Drug Administration (FDA) approval for a new, life-saving therapy. The New Drug Application (NDA) was granted accelerated approval, for the Company’s pharmaceutical client, and is indicated for relapsed… Read More
Imaging Endpoints is a leader in science and technology, providing comprehensive imaging services and technology solutions throughout the clinical trial process. Our 100-plus radiologists and physician specialists take a cutting-edge approach to clinical trials at every stage. Learn more about… Read More
Imaging Endpoints has experienced more than a decade of high growth and is perhaps the fastest-growing imaging CRO globally. That is a testament to our amazing staff and their dedication to Connect Imaging to the Cure. Learn more about opportunities… Read More
Imaging Endpoints is involved in cutting-edge COVID-19 imaging and offers the detection and standardized recording of the clinical and radiological disease features of COVID-19 infection, Radiomic Analysis, CD8+ Analysis and AI Analysis of SARS-CoV-2 for clinical trials. For more information,… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
